Agrify Q3 2022 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $7 million for Q3 2022, down 55.4% from $15.8 million in Q3 2021.

Design and Build Revenue: Declined to $1.3 million from $13 million year-over-year, primarily due to a $5.3 million deferral related to a lawsuit with Bud & Mary's.

Extraction Revenue: Generated $5.7 million, marking the first revenue from this vertical.

Net Loss: $46.3 million, or $17.33 per diluted share, compared to a loss of $9.8 million, or $4.68 per diluted share, in the prior year.

Adjusted EBITDA: Loss of $28.8 million, worsening from a loss of $5.6 million year-over-year.

Cash Position: $12.5 million in cash, down from $56.6 million at the end of 2021.

Bookings: Totaled $11.2 million in Q3, with $5.6 million from extraction products.

Backlog: Approximately $646 million, primarily from future SaaS and production success fees.

2Strategic Updates and Business Highlights

Bud & Mary's Lawsuit: Agrify is pursuing repayment of deferred revenue due to a default on a construction loan by Bud & Mary's, which has led to a significant revenue deferral.

Rapid Deployment Program (RDP): Agrify announced three new RDP customers, with expected sales of $7.5 million in cultivation-related hardware. This program aims to lower entry barriers for customers.

Product Development: Successful commercialization of the PX10 Hydrocarbon cannabis extractor and completion of the new 3.7 VFUs, expected to ship in Q1 2023.

Cost Efficiency Initiatives: Implemented measures to conserve cash and streamline operations in response to market conditions.

3Forward Guidance and Outlook

Revenue Guidance: Revised down to $65 million to $70 million for 2022, from an initial forecast of $70 million to $75 million, primarily due to the deferred revenue from Bud & Mary's.

Market Position: Agrify remains optimistic about future growth, particularly in the extraction business and international markets, especially in Europe.

4Bad News, Challenges, or Points of Concern

Revenue Decline: Significant year-over-year revenue drop due to the lawsuit and cash spending limits imposed by lenders.

Increased Operating Expenses: General and administrative expenses rose sharply, driven by bad debt reserves and severance costs.

Legal Risks: The ongoing lawsuit with Bud & Mary's poses a risk to revenue recognition and could impact future business relationships.

Cash Flow Constraints: Limited by a debt restructuring agreement that caps cash spending, which may hinder operational flexibility.

5Notable Q&A Insights

Market Share and Sales Data: Customers in legacy states are experiencing strong sales, with high-quality products being well-received in the market.

Extraction Business Demand: There is a strong pipeline for extraction products, with expectations of a rebound in Q4 following delays in Q3.

RDP Program Success: The RDP program is gaining traction, allowing customers to start with lower capital investments and providing flexibility in scaling operations.

Bud & Mary's Lawsuit Update: Agrify is confident in its legal position and ability to recover funds, but specifics on the lawsuit's progress were not disclosed due to ongoing legal proceedings. This summary encapsulates the key points from Agrify's Q3 2022 earnings call, highlighting financial performance, strategic initiatives, outlook, and challenges faced by the company.